Cebiotex en la American Society of Clinical Oncology 2021
ASCO21: First-in-human administration of CEB-01, a novel drug delivery implant matrix, in patients with recurrent or locally advanced retroperitoneal soft tissue sarcoma (RPS) after surgery: Preliminary safety and pharmacokinetics report. Download poster Download abstract
La Vanguardia: “Cebiotex, al alza”
Click here to read the online article.
Cebiotex successfully closes a crowdfunding round on Capital Cell
In only six weeks, Cebiotex’s crowdfunding round on Capital Cell has successfully closed, achieving the set objective of 600,000€ and reaching 125% of investment, with 750,000€ The total amount of investors has been 174. In November 2020, Cebiotex announced the launch of a new funding round of 1.6M€, including its 4th crowdfunding. The objective is […]
The European Commission awards Cebiotex the Horizon 2020 Seal of Excellence
On December 15, Cebiotex received the Seal of Excellence awarded by the European Commission. The Seal of Excellence is a quality label awarded to project proposals submitted to Horizon 2020, the EU’s research and innovation funding programme, to help these proposals find alternative funding. The seal recognises the value of the proposal and helps other […]
Semáforo verde en La Vanguardia (Spanish)
La Vanguardia: “Ensayo de una biomembrana para tratar a recién operados de cáncer” (Spanish)
Haz clic aquí para leer el artículo:
Expansión: “Cebiotex abre una ronda de 1,6 millones e inicia un ensayo” (Spanish)
Cebiotex highlighted in Biocat’s new report
Cover of the BioRegió de Catalunya report. Source: Biocat and CataloniaBio & HealthTech. Cebiotex has been highlighted in the recent ‘BioRegió de Catalunya 2020’ report among the nine Biotech and Pharma that are currently in clinical trials in the oncology area. It has also been mentioned as one of the successful startups in the investment […]
First implant of CEB-01 in an adult patient with sarcoma
Dr. Lucas Krauel and Dr. JA González at the Hospital de la Santa Creu i Sant Pau de Barcelona. Promising results after the implant of CEB-01, currently in Clinical Phase In August 2020, CEB-01 was implanted in a first patient with retroperitoneal soft tissue sarcoma at the Hospital de la Santa Creu i Sant Pau […]
Cebiotex awarded the Cecot Recognition of Innovation prize 2018
Founder and CEO Joan Bertran accepting the award. Cebiotex has been renowned with the Cecot Recognition of Innovation prize 2018. Joan Bertran, CEO and founder of Cebiotex, received the award at the Cecot Recognition of Business Progress prize-giving ceremony at the National Theatre of Catalonia. The Cecot Recognition of Business progress awards were launched in […]
